Bioassays and Inactivation of Prions

  1. Stanley B. Prusiner1,2,3
  1. 1Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California 94158
  2. 2Department of Neurology, University of California, San Francisco, San Francisco, California 94158
  3. 3Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, California 94158
  1. Correspondence: stanley.prusiner{at}ucsf.edu

Abstract

The experimental study of prions requires a model for their propagation. However, because prions lack nucleic acids, the simple techniques used to replicate bacteria and viruses are not applicable. For much of the history of prion research, time-consuming bioassays in animals were the only option for measuring infectivity. Although cell models and other in vitro tools for the propagation of prions have been developed, they all suffer limitations, and animal bioassays remain the gold standard for measuring infectivity. A wealth of recent data argues that both β-amyloid (Aβ) and tau proteins form prions that cause Alzheimer’s disease, and α-synuclein forms prions that cause multiple system atrophy and Parkinson’s disease. Cell and animal models that recapitulate some of the key features of cell-to-cell spreading and distinct strains of prions can now be measured.



Also in this Collection

      | Table of Contents

      This Article

      1. Cold Spring Harb. Perspect. Biol. 9: a023499 Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved

      Article Category

      Updates/Comments

      1. Submit Updates/Comments
      2. No Updates/Comments published

      Subject Collections

      1. Prion Biology

      Share

      In this Collection